Pfizer expects to file for full US Food and Drug Administration approval for its Covid-19 vaccine for people ages 16 to 85 this month.
Mandatory Credit: Mark Makela/Getty Images
Stories this photo appears in:
Pfizer to seek authorization for Covid-19 vaccine for children ages 2 to 11 in September
Pfizer expects to file for full US Food and Drug Administration approval for its Covid-19 vaccine for people ages 16 to 85 this month, and will seek emergency use authorization for its vaccine for children ages 2 to 11 in September, the company said during an earnings call on Tuesday.
